Fiscal Period | 2025 | 2024 | 2023 | 2022 |
---|---|---|---|---|
Period End Date | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
Total Operating Expense | 7.80 | 26.78 | 17.15 | 10.49 |
Other Net | 0.06 | 0.05 | 0.48 | 0.83 |
Diluted Weighted Average Shares | 4.00 | 3.91 | 4.00 | 4.00 |
Depreciation/ Amortization | 0.01 | 0.01 | 0.00 | 0.01 |
Operating Income | -0.38 | 1.05 | 0.66 | -0.09 |
Net Income | -0.67 | 0.55 | 0.60 | 0.33 |
Income Availableto Com Excl Extra Ord | -0.67 | 0.55 | 0.60 | 0.33 |
Net Income Before Taxes | -0.67 | 0.70 | 0.72 | 0.33 |
Other Operating Expenses Total | 0.39 | 0.37 | 0.29 | 0.53 |
Net Income After Taxes | -0.67 | 0.55 | 0.60 | 0.33 |
Income Availableto Com Incl Extra Ord | -0.67 | 0.55 | 0.60 | 0.33 |
Costof Revenue Total | 6.82 | 25.95 | 16.51 | 9.65 |
Gross Profit | 0.60 | 1.88 | 1.30 | 0.75 |
Interest Inc( Exp) Net- Non- Op Total | -0.35 | -0.41 | -0.42 | -0.41 |
Diluted Net Income | -0.67 | 0.55 | 0.60 | 0.33 |
Provisionfor Income Taxes | 0.01 | 0.15 | 0.12 | 0.00 |
period Type | - | - | - | - |
Net Income Before Extra Items | -0.67 | 0.55 | 0.60 | 0.33 |
Total Revenue | 7.42 | 27.84 | 17.81 | 10.40 |
period Length | 12.00 | 12.00 | 12.00 | 12.00 |
Revenue | 7.42 | 27.84 | 17.81 | 10.40 |
Selling/ General/ Admin Expenses Total | 0.58 | 0.45 | 0.35 | 0.30 |
Diluted Normalized EPS | -0.17 | 0.14 | 0.15 | 0.08 |
Diluted EPS Excluding Extra Ord Items | -0.17 | 0.14 | 0.15 | 0.08 |
Total Adjustmentsto Net Income | - | - | 0.00 | - |
Unusual Expense( Income) | - | - | 0.00 | 0.00 |
Vivanza Biosciences Dividend Vivanza Biosciences Bonus Vivanza Biosciences News Vivanza Biosciences AGM Vivanza Biosciences Rights Vivanza Biosciences Splits Vivanza Biosciences Board Meetings Vivanza Biosciences Key Metrics Vivanza Biosciences Shareholdings Vivanza Biosciences Balance Sheet Vivanza Biosciences Cashflow Vivanza Biosciences Q1 Results Vivanza Biosciences Q2 Results Vivanza Biosciences Q3 Results Vivanza Biosciences Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks